Friday, September 18, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorycounterfeit peptidesracgpaustraliapatient safety

Australian patient tears oesophagus after counterfeit peptide use, RACGP reports

The college's newsGP reports a serious injury tied to a fake peptide product, adding to clinician warnings about gray-market supply.

DO
By Daniel Okafor · Regulatory Correspondent

The wire

  1. 01RACGP's newsGP reports a patient suffered a torn oesophagus following use of a counterfeit peptide product.
  2. 02Clinicians and pharmacists fielding questions about online peptide sourcing now have a documented harm case to cite when counselling patients.
  3. 03Details of the product, dose and route are limited in the report, and a single case cannot establish how common such injuries are.

From the source

newsGP - Patient suffers torn oesophagus after counterfeit peptide use

Read at www1.racgp.org.au